Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Super Bank Indonesia Tbk. (SUPA) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Super Bank Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Super Bank Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Super Bank Indonesia Tbk. trades at Rp540 (market cap 19.13T, 68.31M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 60.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Super Bank Indonesia Tbk. is more actively traded (68.31M versus 41.7K). Which is the better fit depends on your goals.

DGNSSUPA
Market Cap
316.25B19.13T
Volume
41.7K68.31M
Lot
417683.12K
Turnover
9.66M37.01B
Average Price
231.65541.76
Value
9.66M37.01B
Indicative Equilibrium Price
230540
Indicative Equilibrium Volume
2.4K11.06K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
SUPA
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Super Bank Indonesia Tbk.

PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.

Read more on SUPA